ADHD Drug Atomoxetine Does Not Increase Risk for Suicidal Events
The FDA has warned that atomoxetine might cause greater incidence of suicidal thoughts or behavior for over a decade. New research by the University of Florida College of Pharmacy finds no confirming evidence for the warning.
ADHD News Feed
|
posted by
Janice Rodden
Next Blog » Plastic Softening Phthalates Linked to ADHD in Children Treated in Pediatric Intensive Care Units
Previous Blog « Study Suggests PS-Omega-3 Medical Food May Reduce ADHD Symptoms